A citation-based method for searching scientific literature

Andreea Catana, Adina Patricia Apostu, Razvan-Geo Antemie. Med Pharm Rep 2019
Times Cited: 7







List of co-cited articles
13 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Nasim Mavaddat, Daniel Barrowdale, Irene L Andrulis, Susan M Domchek, Diana Eccles, Heli Nevanlinna, Susan J Ramus, Amanda Spurdle, Mark Robson, Mark Sherman,[...]. Cancer Epidemiol Biomarkers Prev 2012
328
42

Linkage of early-onset familial breast cancer to chromosome 17q21.
J M Hall, M K Lee, B Newman, J E Morrow, L A Anderson, B Huey, M C King. Science 1990
28

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
28

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
28

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
Joaquin Mateo, Suzanne Carreira, Shahneen Sandhu, Susana Miranda, Helen Mossop, Raquel Perez-Lopez, Daniel Nava Rodrigues, Dan Robinson, Aurelius Omlin, Nina Tunariu,[...]. N Engl J Med 2015
28


Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.
Timothy R Rebbeck, Nandita Mitra, Fei Wan, Olga M Sinilnikova, Sue Healey, Lesley McGuffog, Sylvie Mazoyer, Georgia Chenevix-Trench, Douglas F Easton, Antonis C Antoniou,[...]. JAMA 2015
252
28

Hereditary breast and ovarian cancer: new genes in confined pathways.
Finn Cilius Nielsen, Thomas van Overeem Hansen, Claus Storgaard Sørensen. Nat Rev Cancer 2016
186
28

HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures.
Helen Davies, Dominik Glodzik, Sandro Morganella, Lucy R Yates, Johan Staaf, Xueqing Zou, Manasa Ramakrishna, Sancha Martin, Sandrine Boyault, Anieta M Sieuwerts,[...]. Nat Med 2017
354
28

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
867
28

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial.
Andrew Tutt, Holly Tovey, Maggie Chon U Cheang, Sarah Kernaghan, Lucy Kilburn, Patrycja Gazinska, Julie Owen, Jacinta Abraham, Sophie Barrett, Peter Barrett-Lee,[...]. Nat Med 2018
337
28

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.
Mark Robson, Seock-Ah Im, Elżbieta Senkus, Binghe Xu, Susan M Domchek, Norikazu Masuda, Suzette Delaloge, Wei Li, Nadine Tung, Anne Armstrong,[...]. N Engl J Med 2017
28

Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.
Jennifer K Litton, Hope S Rugo, Johannes Ettl, Sara A Hurvitz, Anthony Gonçalves, Kyung-Hun Lee, Louis Fehrenbacher, Rinat Yerushalmi, Lida A Mina, Miguel Martin,[...]. N Engl J Med 2018
644
28

A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.
Ashton C Berger, Anil Korkut, Rupa S Kanchi, Apurva M Hegde, Walter Lenoir, Wenbin Liu, Yuexin Liu, Huihui Fan, Hui Shen, Visweswaran Ravikumar,[...]. Cancer Cell 2018
215
14

BRCA2 alteration is important in clear cell carcinoma of the ovary.
M J Goodheart, S L Rose, M Hattermann-Zogg, B J Smith, B R De Young, R E Buller. Clin Genet 2009
11
14

Inherited Mutations in Women With Ovarian Carcinoma.
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
353
14

PARP1 Links CHD2-Mediated Chromatin Expansion and H3.3 Deposition to DNA Repair by Non-homologous End-Joining.
Martijn S Luijsterburg, Inge de Krijger, Wouter W Wiegant, Rashmi G Shah, Godelieve Smeenk, Anton J L de Groot, Alex Pines, Alfred C O Vertegaal, Jacqueline J L Jacobs, Girish M Shah,[...]. Mol Cell 2016
140
14

Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.
Sarah L Sawyer, Lei Tian, Marketta Kähkönen, Jeremy Schwartzentruber, Martin Kircher, Jacek Majewski, David A Dyment, A Micheil Innes, Kym M Boycott, Lisa A Moreau,[...]. Cancer Discov 2015
197
14

ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes.
Amanda B Spurdle, Sue Healey, Andrew Devereau, Frans B L Hogervorst, Alvaro N A Monteiro, Katherine L Nathanson, Paolo Radice, Dominique Stoppa-Lyonnet, Sean Tavtigian, Barbara Wappenschmidt,[...]. Hum Mutat 2012
188
14

A small-cell lung cancer genome with complex signatures of tobacco exposure.
Erin D Pleasance, Philip J Stephens, Sarah O'Meara, David J McBride, Alison Meynert, David Jones, Meng-Lay Lin, David Beare, King Wai Lau, Chris Greenman,[...]. Nature 2010
767
14


Cancer of the breast as a familial disease.
E Papadrianos, C D Haagensen, E Cooley. Ann Surg 1967
24
14


Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.
T Kainu, S H Juo, R Desper, A A Schaffer, E Gillanders, E Rozenblum, D Freas-Lutz, D Weaver, D Stephan, J Bailey-Wilson,[...]. Proc Natl Acad Sci U S A 2000
145
14

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.
J M Piek, P J van Diest, R P Zweemer, J W Jansen, R J Poort-Keesom, F H Menko, J J Gille, A P Jongsma, G Pals, P Kenemans,[...]. J Pathol 2001
475
14

Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma.
Robert A Soslow, Guangming Han, Kay J Park, Karuna Garg, Narciso Olvera, David R Spriggs, Noah D Kauff, Douglas A Levine. Mod Pathol 2012
122
14

A comprehensive catalogue of somatic mutations from a human cancer genome.
Erin D Pleasance, R Keira Cheetham, Philip J Stephens, David J McBride, Sean J Humphray, Chris D Greenman, Ignacio Varela, Meng-Lay Lin, Gonzalo R Ordóñez, Graham R Bignell,[...]. Nature 2010
14

RAD51 paralogs: roles in DNA damage signalling, recombinational repair and tumorigenesis.
Natsuko Suwaki, Kerstin Klare, Madalena Tarsounas. Semin Cell Dev Biol 2011
177
14


Fanconi Anemia Signaling and Cancer.
Manoj Nepal, Raymond Che, Jun Zhang, Chi Ma, Peiwen Fei. Trends Cancer 2017
35
14

BRCA1 and BRCA2: 1994 and beyond.
Steven A Narod, William D Foulkes. Nat Rev Cancer 2004
595
14

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.
Y Lee, A Miron, R Drapkin, M R Nucci, F Medeiros, A Saleemuddin, J Garber, C Birch, H Mou, R W Gordon,[...]. J Pathol 2007
571
14

A Comprehensive Review of Ovarian Serous Carcinoma.
Yuichiro Hatano, Kayoko Hatano, Maho Tamada, Ken-Ichirou Morishige, Hiroyuki Tomita, Hiroyuki Yanai, Akira Hara. Adv Anat Pathol 2019
11
14

Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation.
S A Gayther, W Warren, S Mazoyer, P A Russell, P A Harrington, M Chiano, S Seal, R Hamoudi, E J van Rensburg, A M Dunning,[...]. Nat Genet 1995
427
14

Role of BRCA Mutations in the Modulation of Response to Platinum Therapy.
Sanghamitra Mylavarapu, Asmita Das, Monideepa Roy. Front Oncol 2018
54
14

Secondary somatic mutations restoring BRCA1/2 predict chemotherapy resistance in hereditary ovarian carcinomas.
Barbara Norquist, Kaitlyn A Wurz, Christopher C Pennil, Rochelle Garcia, Jenny Gross, Wataru Sakai, Beth Y Karlan, Toshiyasu Taniguchi, Elizabeth M Swisher. J Clin Oncol 2011
374
14


Resurrection of PARP Inhibitors in Breast Cancer.
Tomas G Lyons, Mark E Robson. J Natl Compr Canc Netw 2018
10
14

The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.
Lynn C Hartmann, Noralane M Lindor. N Engl J Med 2016
150
14

Biallelic Inactivation of BRCA2 in Platinum-sensitive Metastatic Castration-resistant Prostate Cancer.
Heather H Cheng, Colin C Pritchard, Thomas Boyd, Peter S Nelson, Bruce Montgomery. Eur Urol 2016
172
14

Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities.
Joshua Z Press, Alessandro De Luca, Niki Boyd, Sean Young, Armelle Troussard, Yolanda Ridge, Pardeep Kaurah, Steve E Kalloger, Katherine A Blood, Margaret Smith,[...]. BMC Cancer 2008
210
14

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.
M Esteller, J M Silva, G Dominguez, F Bonilla, X Matias-Guiu, E Lerma, E Bussaglia, J Prat, I C Harkes, E A Repasky,[...]. J Natl Cancer Inst 2000
814
14

Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium.
Deborah Thompson, Csilla I Szabo, Jon Mangion, Rogier A Oldenburg, Fabrice Odefrey, Sheila Seal, Rita Barfoot, Karin Kroeze-Jansema, Dawn Teare, Nazneen Rahman,[...]. Proc Natl Acad Sci U S A 2002
64
14

Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers.
Maria L Carcangiu, Paolo Radice, Siranoush Manoukian, Gianbattista Spatti, Morena Gobbo, Valeria Pensotti, Rosella Crucianelli, Barbara Pasini. Int J Gynecol Pathol 2004
93
14

Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer.
Matti Annala, Werner J Struss, Evan W Warner, Kevin Beja, Gillian Vandekerkhove, Amanda Wong, Daniel Khalaf, Irma-Liisa Seppälä, Alan So, Gregory Lo,[...]. Eur Urol 2017
121
14

BRCA1 and BRCA2: different roles in a common pathway of genome protection.
Rohini Roy, Jarin Chun, Simon N Powell. Nat Rev Cancer 2011
726
14

Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.
Gail P Risbridger, Renea A Taylor, David Clouston, Ania Sliwinski, Heather Thorne, Sally Hunter, Jason Li, Gillian Mitchell, Declan Murphy, Mark Frydenberg,[...]. Eur Urol 2015
72
14

Evidence for a dualistic model of high-grade serous carcinoma: BRCA mutation status, histology, and tubal intraepithelial carcinoma.
Brooke E Howitt, Suchanan Hanamornroongruang, Douglas I Lin, James E Conner, Stephanie Schulte, Neil Horowitz, Christopher P Crum, Emily E Meserve. Am J Surg Pathol 2015
61
14

ClinVar: public archive of relationships among sequence variation and human phenotype.
Melissa J Landrum, Jennifer M Lee, George R Riley, Wonhee Jang, Wendy S Rubinstein, Deanna M Church, Donna R Maglott. Nucleic Acids Res 2014
14

Whole-genome characterization of chemoresistant ovarian cancer.
Ann-Marie Patch, Elizabeth L Christie, Dariush Etemadmoghadam, Dale W Garsed, Joshy George, Sian Fereday, Katia Nones, Prue Cowin, Kathryn Alsop, Peter J Bailey,[...]. Nature 2015
757
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.